Evonik is one of the world leaders in specialty chemicals. The company is active in >100 countries around the world & generated sales of €18.5 billion & an operating profit (adjusted EBITDA) of €2.49 billion in 2022. Evonik is one of the world’s largest CDMOs with capabilities to manufacture customized APIs & HPAPIs. To address the specific needs of large or complex projects, they have established a broad portfolio of differentiating technologies. These technologies include catalytic & biocatalytic reactions, large-scale cryogenic chemistry, continuous processing, fermentation, PEGs & mPEGs, catalysts, & polymer APIs.